Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions.

Schechter, C. B., & Mandelblatt, J. (2021). Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions. Journal of Clinical Oncology, 39(26), 2893-2902. https://doi.org/10.1200/jco.21.00651